Market Cap 199.34M
Revenue (ttm) 1.08B
Net Income (ttm) 95.40M
EPS (ttm) N/A
PE Ratio 1.40
Forward PE 2.30
Profit Margin 8.83%
Debt to Equity Ratio -2.12
Volume 4,904,188
Avg Vol 1,641,046
Day's Range N/A - N/A
Shares Out 59.33M
Stochastic %K 3%
Beta 1.09
Analysts Hold
Price Target $8.00

Company Profile

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headqu...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 862 401 0000
Address:
300 Kimball Drive, Suite 300, Parsippany, United States
LordWorld
LordWorld May. 13 at 8:56 PM
$EMBC If the situation worsens, they may put themselves up for sale. The buyout price, based on market capitalization, is a minimum of $10 and a maximum of $28 per share. This includes the company's debt.
0 · Reply
LordWorld
LordWorld May. 13 at 8:52 PM
$EMBC The probability of bankruptcy by the end of the year is 1%. 😂
0 · Reply
JOHNNY_DANGER
JOHNNY_DANGER May. 13 at 8:29 PM
$EMBC Is it possible that they file for chapter 7 bk by years end ?
1 · Reply
assetmogul2
assetmogul2 May. 13 at 8:03 PM
$EMBC holding 170k shares and will decide what I am doing after hearing this speech tonight
0 · Reply
javiarza
javiarza May. 13 at 7:59 PM
$EMBC 500 shares at 3,13$ - average down. Let’ s see the conference now!
0 · Reply
derdo
derdo May. 13 at 7:54 PM
$EMBC as i said, garbage
0 · Reply
OrangeJoolius
OrangeJoolius May. 13 at 7:51 PM
$EMBC As I said, max short.
2 · Reply
showmethemoney75
showmethemoney75 May. 13 at 7:47 PM
0 · Reply
derdo
derdo May. 13 at 7:42 PM
$EMBC me warned but nobody listened. garbage
0 · Reply
LordWorld
LordWorld May. 13 at 7:33 PM
$EMBC I'm betting on this conference! Which will begin immediately after the market closes.
0 · Reply
Latest News on EMBC
Embecta price target lowered to $5 from $12 at Mizuho

2026-05-07T06:57:11.000Z - 6 days ago

Embecta price target lowered to $5 from $12 at Mizuho


Embecta Earnings Call Transcript: Q2 2026

May 5, 2026, 8:00 AM EDT - 8 days ago

Embecta Earnings Call Transcript: Q2 2026


Embecta reports Q2 adjusted EPS 27c, consensus 42c

2026-05-05T10:48:58.000Z - 8 days ago

Embecta reports Q2 adjusted EPS 27c, consensus 42c


embecta Announces Quarterly Cash Dividend

May 5, 2026, 6:30 AM EDT - 8 days ago

embecta Announces Quarterly Cash Dividend


Embecta management to meet virtually with BTIG

2026-04-29T17:50:52.000Z - 14 days ago

Embecta management to meet virtually with BTIG


embecta to Report Fiscal Second Quarter Financial Results

Apr 21, 2026, 5:00 PM EDT - 21 days ago

embecta to Report Fiscal Second Quarter Financial Results


Embecta price target lowered to $12 from $14 at Mizuho

2026-04-13T14:41:50.000Z - 4 weeks ago

Embecta price target lowered to $12 from $14 at Mizuho


Embecta price target lowered to $22 from $25 at BTIG

2026-04-13T11:55:26.000Z - 4 weeks ago

Embecta price target lowered to $22 from $25 at BTIG


Embecta acquiring Owen Mumford Holdings

2026-03-19T10:46:35.000Z - 7 weeks ago

Embecta acquiring Owen Mumford Holdings


Embecta elects CEO Devdatt Kurdikar as chairman

2026-02-11T21:21:38.000Z - 3 months ago

Embecta elects CEO Devdatt Kurdikar as chairman


Embecta Earnings Call Transcript: Q1 2026

Feb 5, 2026, 8:00 AM EST - 3 months ago

Embecta Earnings Call Transcript: Q1 2026


Embecta reports Q1 adjusted EPS 71c, consensus 67c

2026-02-05T11:42:06.000Z - 3 months ago

Embecta reports Q1 adjusted EPS 71c, consensus 67c


embecta to Report Fiscal First Quarter Financial Results

Jan 22, 2026, 5:00 PM EST - 3 months ago

embecta to Report Fiscal First Quarter Financial Results


Embecta Earnings Call Transcript: Q4 2025

Nov 25, 2025, 8:00 AM EST - 6 months ago

Embecta Earnings Call Transcript: Q4 2025


Embecta reports Q4 adjusted EPS 50c, consensus 46c

2025-11-25T11:35:52.000Z - 6 months ago

Embecta reports Q4 adjusted EPS 50c, consensus 46c


Embecta sees FY26 adjusted EPS $2.80-$3.00, consensus $2.95

2025-11-25T11:35:41.000Z - 6 months ago

Embecta sees FY26 adjusted EPS $2.80-$3.00, consensus $2.95


embecta announces changes to Board of Directors

Nov 17, 2025, 5:00 PM EST - 6 months ago

embecta announces changes to Board of Directors


Embecta management to meet with BTIG

2025-09-09T14:20:26.000Z - 8 months ago

Embecta management to meet with BTIG


embecta to Participate in Investor Events

Aug 26, 2025, 5:00 PM EDT - 9 months ago

embecta to Participate in Investor Events


Embecta price target lowered to $11 from $18 at BofA

2025-08-08T18:45:13.000Z - 9 months ago

Embecta price target lowered to $11 from $18 at BofA


Embecta Earnings Call Transcript: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 9 months ago

Embecta Earnings Call Transcript: Q3 2025


Embecta reports Q3 adjusted EPS $1.12 vs. 74c last year

2025-08-08T10:35:32.000Z - 9 months ago

Embecta reports Q3 adjusted EPS $1.12 vs. 74c last year


embecta to Report Fiscal Third Quarter 2025 Financial Results

Jul 24, 2025, 5:00 PM EDT - 10 months ago

embecta to Report Fiscal Third Quarter 2025 Financial Results


Embecta price target lowered to $12 from $13 at Mizuho

2025-07-16T11:42:06.000Z - 10 months ago

Embecta price target lowered to $12 from $13 at Mizuho


Embecta price target lowered to $13 from $15 at Mizuho

2025-05-23T12:51:11.000Z - 1 year ago

Embecta price target lowered to $13 from $15 at Mizuho


Embecta price target lowered to $25 from $26 at BTIG

2025-05-23T11:25:30.000Z - 1 year ago

Embecta price target lowered to $25 from $26 at BTIG


Embecta Transcript: Investor Day 2025

May 22, 2025, 9:00 AM EDT - 1 year ago

Embecta Transcript: Investor Day 2025


Embecta Earnings Call Transcript: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Earnings Call Transcript: Q2 2025


Embecta to host Analyst and Investor Day on May 22, 2025

Apr 28, 2025, 7:30 AM EDT - 1 year ago

Embecta to host Analyst and Investor Day on May 22, 2025


Embecta Earnings Call Transcript: Q1 2025

Feb 6, 2025, 8:00 AM EST - 1 year ago

Embecta Earnings Call Transcript: Q1 2025


embecta to Report Fiscal First Quarter 2025 Financial Results

Jan 23, 2025, 5:00 PM EST - 1 year ago

embecta to Report Fiscal First Quarter 2025 Financial Results


Overlooked Stock: EMBC

Nov 27, 2024, 4:38 PM EST - 1 year ago

Overlooked Stock: EMBC


Embecta Earnings Call Transcript: Q4 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

Embecta Earnings Call Transcript: Q4 2024


Embecta Earnings Call Transcript: Q3 2024

Aug 9, 2024, 8:00 AM EDT - 1 year ago

Embecta Earnings Call Transcript: Q3 2024


embecta to Report Fiscal Third Quarter 2024 Financial Results

Jul 18, 2024, 5:00 PM EDT - 1 year ago

embecta to Report Fiscal Third Quarter 2024 Financial Results


Embecta (EMBC) CEO on Diabetes Treatment Market

May 17, 2024, 4:30 PM EDT - 2 years ago

Embecta (EMBC) CEO on Diabetes Treatment Market


Embecta Transcript: BofA Securities 2024 Health Care Conference

May 16, 2024, 1:00 PM EDT - 2 years ago

Embecta Transcript: BofA Securities 2024 Health Care Conference


Embecta Earnings Call Transcript: Q2 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Earnings Call Transcript: Q2 2024


embecta to Report Fiscal Second Quarter 2024 Financial Results

Apr 23, 2024, 5:00 PM EDT - 2 years ago

embecta to Report Fiscal Second Quarter 2024 Financial Results


Embecta Earnings Call Transcript: Q1 2024

Feb 9, 2024, 8:00 AM EST - 2 years ago

Embecta Earnings Call Transcript: Q1 2024


embecta to Report Fiscal First Quarter 2024 Financial Results

Jan 24, 2024, 5:00 PM EST - 2 years ago

embecta to Report Fiscal First Quarter 2024 Financial Results


No embecta-made syringes impacted by FDA safety communication

Dec 1, 2023, 6:00 AM EST - 2 years ago

No embecta-made syringes impacted by FDA safety communication


embecta to Participate in Investor Conferences

Nov 29, 2023, 5:00 PM EST - 2 years ago

embecta to Participate in Investor Conferences


LordWorld
LordWorld May. 13 at 8:56 PM
$EMBC If the situation worsens, they may put themselves up for sale. The buyout price, based on market capitalization, is a minimum of $10 and a maximum of $28 per share. This includes the company's debt.
0 · Reply
LordWorld
LordWorld May. 13 at 8:52 PM
$EMBC The probability of bankruptcy by the end of the year is 1%. 😂
0 · Reply
JOHNNY_DANGER
JOHNNY_DANGER May. 13 at 8:29 PM
$EMBC Is it possible that they file for chapter 7 bk by years end ?
1 · Reply
assetmogul2
assetmogul2 May. 13 at 8:03 PM
$EMBC holding 170k shares and will decide what I am doing after hearing this speech tonight
0 · Reply
javiarza
javiarza May. 13 at 7:59 PM
$EMBC 500 shares at 3,13$ - average down. Let’ s see the conference now!
0 · Reply
derdo
derdo May. 13 at 7:54 PM
$EMBC as i said, garbage
0 · Reply
OrangeJoolius
OrangeJoolius May. 13 at 7:51 PM
$EMBC As I said, max short.
2 · Reply
showmethemoney75
showmethemoney75 May. 13 at 7:47 PM
0 · Reply
derdo
derdo May. 13 at 7:42 PM
$EMBC me warned but nobody listened. garbage
0 · Reply
LordWorld
LordWorld May. 13 at 7:33 PM
$EMBC I'm betting on this conference! Which will begin immediately after the market closes.
0 · Reply
LordWorld
LordWorld May. 13 at 7:24 PM
$EMBC ✊✊✊
0 · Reply
LuckyStar77
LuckyStar77 May. 13 at 6:47 PM
$EMBC Added more at 3.17. This is definitely not a risk-free trade, but I still see a real turnaround setup here. The company has an established global diabetes care business, strong institutional ownership, and is moving beyond its legacy insulin delivery products with its recent acquisition. Revenue pressure is real, but at these levels, I believe a lot of bad news may already be priced in. Hopefully I’m right, but we’ll see. Holding and waiting. 🚀⭐
1 · Reply
showmethemoney75
showmethemoney75 May. 13 at 6:30 PM
1 · Reply
Wonderfulnewz
Wonderfulnewz May. 13 at 6:26 PM
$EMBC the problem with these guys is the $1.3 billion in debt and a forecast to see sales shrink by 7% in 2026. They have an infrastructure based on flat growth so it’s negative operating leverage. Add to that an acquisition and the issues that come with that. It’s probably worth $3-4 but it’s not a pretty picture
1 · Reply
AlarmedSheiky
AlarmedSheiky May. 13 at 5:09 PM
$EMBC New silver lining! I feel comfortable taking profit on a bunch of short term winners because I know I have this hideous beast to unload come tax season!
2 · Reply
derdo
derdo May. 13 at 4:51 PM
$EMBC looks like time to short until 2.50.
1 · Reply
showmethemoney75
showmethemoney75 May. 13 at 4:40 PM
$EMBC Where is the 100 million buyback If they were executing it this would not be going in the dumpsters still. Why not now unless they feel it will fall more or worst yet they were never really going to….?????
2 · Reply
ALag77
ALag77 May. 13 at 3:59 PM
$EMBC 'Max' shorting at ATL's, right after an already 65% dump? This thing can just as easily pop up, as much as it can creep more down. I'm in @ 3.17.... I'll risk the buy side on this one.
2 · Reply
OrangeJoolius
OrangeJoolius May. 13 at 3:43 PM
$EMBC I'm max short here, the company is trash until the management does something to stem the tide. Shorts are well in control and if you can't beat them, join them.
2 · Reply
Xxxxcccemre
Xxxxcccemre May. 13 at 3:30 PM
$EMBC worst investment ever ….. I first bought in here at 5.20 and averaged down and averaged down 😂andddd averaged down thinking it was the bottom …. NOPE
2 · Reply
Gena45
Gena45 May. 13 at 3:12 PM
$EMBC This is crazy Not even a bounce Holding 2k @$3.85 😬
2 · Reply
LordWorld
LordWorld May. 13 at 2:55 PM
$EMBC Buy back!
0 · Reply